trans-2,3-Dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: Synthesis, Resolution, and Preliminary Pharmacological Characterization of a New Dopamine D1Receptor Full Agonist
Citations Over Time
Abstract
We report the synthesis of trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline hydrochloride 6 and the resolution of its enantiomers. This new compound is an oxygen bioisostere of the potent dopamine D1-selective full agonist dihydrexidine. The initial synthetic approach involved, as a key step, a Suzuki coupling between a chromene triflate and a boronate ester, followed by isoquinoline formation and reduction of the resulting isoquinoline. Subsequently, a more efficient route was developed that involved conjugate addition of an aryl Grignard reagent to a 2-nitrochromene. The title compound possessed high affinity (Ki=20-30 nM) for porcine D1-like receptors in native striatal tissue and full intrinsic activity at cloned human dopamine D1 receptors but had much lower affinity at dopamine D2-like receptors (Ki=3000 nM). The binding and functional properties of this compound illustrate again the utility of constructing dopamine D1 agonist ligands around the beta-phenyldopamine pharmacophore template.
Related Papers
- → Design and synthesis of a selective EP4-receptor agonist. Part 3: 16-phenyl-5-thiaPGE1 and 9-β-halo derivatives with improved stability(2002)30 cited
- → In silico guided design of non-covalent inhibitors of DprE1: synthesis and biological evaluation(2021)9 cited
- → ChemInform Abstract: A Novel Route to Isoquinoline[2,1‐g][1,6]naphthyridine, Pyrazolo[5,1‐a]isoquinoline and Pyridazino[4′,5′:3,4]pyrazolo[5,1‐a]isoquinoline Derivatives with Evaluation of Antitumor Activities.(2013)
- → ChemInform Abstract: Synthesis and Reactivity of 2‐Chloro‐3‐formylpyrido[2,1‐a]isoquinoline Derivatives (III). A Novel Route to Pyrazolo[3′,4′:4,5]pyrido[2,1‐a]isoquinoline and Isoquinolino[2,1‐g][1,6]naphthyridines.(2013)
- Study on Synthesis of isoquinoline Derivatives(2008)